Cite

HARVARD Citation

    Behera, M. et al. (2020). Trimodality Therapy in the Treatment of Stage III N2‐Positive Non‐Small Cell Lung Cancer: A National Cancer Database Analysis. Oncologist. pp. e964-e975. [Online]. 
  
Back to record